GGrantIndex
← Leaderboards

Thomas Harrison Barker

Georgia Institute Of Technology

$9,624,712
Attributed
$12,474,855
Total exposure
11
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.8M · FY200825
$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$12,474,855 · 11

By mechanism

R01$11,173,805 · 5
R21$1,255,550 · 3
R13$45,500 · 3

Top collaborators

Most similar at Georgia Institute Of Technology

Same institution · by research overlap

Others in their field

Top investigators on “Molecular

Research focus

MolecularTissuesBaseResponseInnovationIn VivoCellsTechnologyAffinityIn VitroWound HealingAffectCicatrixFda ApprovedDesignExtracellular MatrixAmericanFibrosisWoundFibroblastsDisease ProgressionPhenotypeEngineeringBlood Vessels

Grant awards (32)

2025 Biennial Meeting of the American Society for Matrix Biology (ASMB)$28,000
R13 · FY2025 · AR · contact PI
Modeling to Design Treatments for Idiopathic Lung Fibrosis$537,250
R01 · FY2024 · HL
Modeling to Design Treatments for Idiopathic Lung Fibrosis$548,214
R01 · FY2023 · HL
Modeling to Design Treatments for Idiopathic Lung Fibrosis$548,214
R01 · FY2022 · HL
2022 American Society for Matrix Biology Workshop on Fibroblasts: The Many Faces of Fibroblasts$10,000
R13 · FY2022 · HL · contact PI
Modeling to Design Treatments for Idiopathic Lung Fibrosis$548,214
R01 · FY2021 · HL
Platelet-like particles for augmenting hemostasis$656,680
R01 · FY2019 · HL · contact PI
Mechanosensors that detect and treat Lung Fibrosis$615,406
R01 · FY2019 · HL · contact PI
2019 American Society for Matrix Biology Workshop on Fibroblasts: The Arbiters of Matrix Remodeling$7,500
R13 · FY2019 · HL · contact PI
Platelet-like particles for augmenting hemostasis$659,445
R01 · FY2018 · HL · contact PI
Mechanosensors that detect and treat Lung Fibrosis$615,406
R01 · FY2018 · HL · contact PI
Targeting the alpha v integrin mechanotransduction axis in IPF$391,820
R01 · FY2018 · HL · contact PI
Mechanosensors that detect and treat Lung Fibrosis$675,986
R01 · FY2017 · HL · contact PI
Platelet-like particles for augmenting hemostasis$662,132
R01 · FY2017 · HL · contact PI
Targeting the alpha v integrin mechanotransduction axis in IPF$391,820
R01 · FY2017 · HL · contact PI
Platelet-like particles for augmenting hemostasis$705,500
R01 · FY2016 · HL · contact PI
Mechanosensors that detect and treat Lung Fibrosis$674,592
R01 · FY2016 · HL · contact PI
Targeting the alpha v integrin mechanotransduction axis in IPF$311,149
R01 · FY2016 · HL · contact PI
Targeting the alpha v integrin mechanotransduction axis in IPF$69,991
R01 · FY2016 · HL · contact PI
Mechanosensors that detect and treat Lung Fibrosis$691,620
R01 · FY2015 · HL · contact PI
Targeting the alpha v integrin mechanotransduction axis in IPF$395,240
R01 · FY2015 · HL · contact PI
Augmentation of Hemostasis in Pediatric Cardiopulmonary Bypass$198,311
R21 · FY2015 · EB
Augmentation of Hemostasis in Pediatric Cardiopulmonary Bypass$252,179
R21 · FY2014 · EB
Engineering fibrin polymers for enhanced angiogenesis$304,164
R01 · FY2013 · EB · contact PI
Fibrinogen-Triggered Matrix Assembly from Designed Peptide-Polymer Conjugates$174,306
R21 · FY2013 · EB · contact PI
Engineering fibrin polymers for enhanced angiogenesis$403,828
R01 · FY2012 · EB · contact PI
Fibrinogen-Triggered Matrix Assembly from Designed Peptide-Polymer Conjugates$209,842
R21 · FY2012 · EB · contact PI
Engineering fibrin polymers for enhanced angiogenesis$397,990
R01 · FY2011 · EB · contact PI
Engineering fibrin polymers for enhanced angiogenesis$328,684
R01 · FY2010 · EB · contact PI
Engineering fibrin polymers for enhanced angiogenesis$40,460
R01 · FY2010 · EB · contact PI
Regulating fibrin polymerization through engineered thermo-responsive knob-pocket$184,833
R21 · FY2009 · EB · contact PI
Regulating fibrin polymerization through engineered thermo-responsive knob-pocket$236,079
R21 · FY2008 · EB · contact PI